ConductScience.org, home

Paper41369409

AI-Guided Dual Strategy for Peptide Inhibitor Design Targeting Structural Polymorphs of α-Synuclein Fibrils.

Duan J and 2 others. Cells, 2025. Cited by 0 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. AI-Guided Dual Strategy for Peptide Inhibitor Design Targeting Structural Polymorphs of α-Synuclein Fibrils. Papers, record 41369409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41369409

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
AI-Guided Dual Strategy for Peptide Inhibitor Design Targeting Structural Polymorphs of α-Synuclein Fibrils.
PubMed
Journal
Cells
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-17
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Duan JJinfang
2Zhang HHaoyu
3Sun CChuanqihttps://orcid.org/0000-0002-6443-6407

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
alpha-SynucleinMajor topic
PeptidesMajor topic
Drug DesignMajor topic
AmyloidMajor topic
Humans
Cryoelectron Microscopy
Amino Acid Sequence

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 AG060149NIA NIH HHSUnited StatesR01AG060149PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Update of41279919AI-Guided Dual Strategy for Peptide Inhibitor Design Targeting Structural Polymorphs of α-Synuclein Fibrils.https://conductscience.org/library/papers/41279919

Source PubMed

Download CSV of comments and corrections

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132031280Update on the association between alpha-synuclein and tau with mitochondrial dysfunction: Implications for Parkinson's disease.Eur J Neurosci2021https://conductscience.org/library/papers/32031280PubMed
230473927The Contribution of Tau, Amyloid-Beta and Alpha-Synuclein Pathology to Dementia in Lewy Body Disorders.J Alzheimers Dis Parkinsonism2018https://conductscience.org/library/papers/30473927PubMed
340215967Fibril fuzzy coat is important for α-synuclein pathological transmission activity.Neuron2025https://conductscience.org/library/papers/40215967PubMed
439327912Inhibitor Development for α-Synuclein Fibril's Disordered Region to Alleviate Parkinson's Disease Pathology.J Am Chem Soc2024https://conductscience.org/library/papers/39327912PubMed
537940962Peptide-based approaches to directly target alpha-synuclein in Parkinson's disease.Mol Neurodegener2023https://conductscience.org/library/papers/37940962PubMed
641067404Rising Stars: Molecular Mechanisms and Chemical Interventions of α-Synuclein Amyloid Aggregation in Parkinson's Disease.J Mol Biol2025https://conductscience.org/library/papers/41067404PubMed
731295458Structural Insights into α-Synuclein Fibril Polymorphism: Effects of Parkinson's Disease-Related C-Terminal Truncations.J Mol Biol2019https://conductscience.org/library/papers/31295458PubMed
833548114Seeded assembly in vitro does not replicate the structures of α-synuclein filaments from multiple system atrophy.FEBS Open Bio2021https://conductscience.org/library/papers/33548114PubMed
934265844Highly accurate protein structure prediction with AlphaFold.Nature2021https://conductscience.org/library/papers/34265844PubMed
1039693572Structural commonalities determined by physicochemical principles in the complex polymorphism of the amyloid state of proteins.Biochem J2025https://conductscience.org/library/papers/39693572PubMed
1131105524Spreading of α-Synuclein and Tau: A Systematic Comparison of the Mechanisms Involved.Front Mol Neurosci2019https://conductscience.org/library/papers/31105524PubMed
1240135351Identical Seeding Characteristics and Cryo-EM Filament Structures in FTLD-Synuclein and Typical Multiple System Atrophy.Neuropathol Appl Neurobiol2025https://conductscience.org/library/papers/40135351PubMed
1340231709CPL-Diff: A Diffusion Model for De Novo Design of Functional Peptide Sequences with Fixed Length.Adv Sci (Weinh)2025https://conductscience.org/library/papers/40231709PubMed
1440339505PQK7: A novel peptide inhibitor targeting alpha-synuclein fibrillogenesis in Parkinson's disease.Neuropeptides2025https://conductscience.org/library/papers/40339505PubMed
1540804173Target sequence-conditioned design of peptide binders using masked language modeling.Nat Biotechnol2026https://conductscience.org/library/papers/40804173PubMed
1640288261Structure-based artificial intelligence-aided design of MYC-targeting degradation drugs for cancer therapy.Biochem Biophys Res Commun2025https://conductscience.org/library/papers/40288261PubMed
1740015644Structural basis of a distinct α-synuclein strain that promotes tau inclusion in neurons.J Biol Chem2025https://conductscience.org/library/papers/40015644PubMed
1833094280Differential cross-seeding properties of tau and α-synuclein in mouse models of tauopathy and synucleinopathy.Brain Commun2020https://conductscience.org/library/papers/33094280PubMed
1929969391Cryo-EM structure of alpha-synuclein fibrils.Elife2018https://conductscience.org/library/papers/29969391PubMed
2038198008Distinct tau and alpha-synuclein molecular signatures in Alzheimer's disease with and without Lewy bodies and Parkinson's disease with dementia.Acta Neuropathol2024https://conductscience.org/library/papers/38198008PubMed

See all 48 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn Papers
42972149From structure prediction to ligand-target recognition: expanding the reach of AlphaFold in natural product research.Nat Prod Bioprospect2026https://conductscience.org/library/papers/42972149

Source PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
SNCA6622PubTator's text mininghttps://conductscience.org/library/genes/6622

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41369409

GET https://conductscience.org/api/papers/v1/41369409/references?page=2